These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6189335)

  • 21. Epidermal cell DNA content and intermediate filaments keratin 10 and vimentin after treatment of psoriasis with calcipotriol cream once daily, twice daily and in combination with clobetasone 17-butyrate cream or betamethasone 17-valerate cream: a comparative flow cytometric study.
    Glade CP; Van Erp PE; Van De Kerkhof PC
    Br J Dermatol; 1996 Sep; 135(3):379-84. PubMed ID: 8949429
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recovery of human skin collagen synthesis after short-term topical corticosteroid treatment and comparison between young and old subjects.
    Haapasaari KM; Risteli J; Oikarinen A
    Br J Dermatol; 1996 Jul; 135(1):65-9. PubMed ID: 8776361
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Comparative study of efficacy and effect on plasma cortisol levels of micronised desonide cream 0.1 p. 100 versus betamethasone dipropionate cream 0.05 p. 100 In the treatment of childhood atopic dermatitis].
    Lebrun-Vignes B; Legrain V; Amoric J; Taïeb A
    Ann Dermatol Venereol; 2000; 127(6-7):590-5. PubMed ID: 10930856
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A randomized study of the safety, absorption and efficacy of pimecrolimus cream 1% applied twice or four times daily in patients with atopic dermatitis.
    Ling M; Gottlieb A; Pariser D; Caro I; Stewart D; Scott G; Abrams K
    J Dermatolog Treat; 2005 Aug; 16(3):142-8. PubMed ID: 16096179
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hylan versus corticosteroid versus placebo for treatment of basal joint arthritis: a prospective, randomized, double-blinded clinical trial.
    Heyworth BE; Lee JH; Kim PD; Lipton CB; Strauch RJ; Rosenwasser MP
    J Hand Surg Am; 2008 Jan; 33(1):40-8. PubMed ID: 18261664
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Comparison of 3 corticoid preparations with the vasoconstriction and erythema test].
    Früh H
    Z Hautkr; 1983 Mar; 58(5):317-23. PubMed ID: 6845798
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of betamethasone valerate inhalation on the hypothalamic-pituitary-adrenal axis or normal adults.
    Friedman M; Frears J; Crowley MF
    Postgrad Med J; 1974 Sep; 50 suppl 4():11-14. PubMed ID: 4467151
    [No Abstract]   [Full Text] [Related]  

  • 28. A new formulation of an occlusive dressing containing betamethasone valerate 0.1% in the treatment of mild to moderate psoriasis.
    Pacifico A; Daidone R; Peris K
    J Eur Acad Dermatol Venereol; 2006 Feb; 20(2):153-7. PubMed ID: 16441622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind comparison of quarter strength clobetasol propionate in Unguentum Merck with betamethasone valerate in psoriasis.
    Stankler L
    Br J Clin Pract; 1983; 37(11-12):389-91. PubMed ID: 6367795
    [No Abstract]   [Full Text] [Related]  

  • 30. The impact of a two-compound product containing calcipotriol and betamethasone dipropionate (Daivobet/ Dovobet) on the quality of life in patients with psoriasis vulgaris: a randomized controlled trial.
    van de Kerkhof PC
    Br J Dermatol; 2004 Sep; 151(3):663-8. PubMed ID: 15377355
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Evaluation of the effect on the hypophysis-adrenal system of diflorasone diacetate in comparison to betamethasone 17-valerate in psoriasis patients].
    Albanese A; Califano L; Puglisi A; Silva A
    G Ital Dermatol Venereol; 1982; 117(5):LV-LIX. PubMed ID: 7187414
    [No Abstract]   [Full Text] [Related]  

  • 32. The in vitro metabolism of betamethasone-17-valerate by human skin [proceedings].
    Rawlins MD; Shaw V; Shuster S
    Br J Pharmacol; 1979 Jul; 66(3):441P. PubMed ID: 526730
    [No Abstract]   [Full Text] [Related]  

  • 33. Efficacy of once-daily treatment regimens with calcipotriol/betamethasone dipropionate ointment and calcipotriol ointment in psoriasis vulgaris.
    Kragballe K; Noerrelund KL; Lui H; Ortonne JP; Wozel G; Uurasmaa T; Fleming C; Estebaranz JL; Hanssen LI; Persson LM
    Br J Dermatol; 2004 Jun; 150(6):1167-73. PubMed ID: 15214905
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Concurrent application of tretinoin (retinoic acid) partially protects against corticosteroid-induced epidermal atrophy.
    McMichael AJ; Griffiths CE; Talwar HS; Finkel LJ; Rafal ES; Hamilton TA; Voorhees JJ
    Br J Dermatol; 1996 Jul; 135(1):60-4. PubMed ID: 8776360
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An 18-month follow-up study after randomized treatment of phimosis in boys with topical steroid versus placebo.
    Lund L; Wai KH; Mui LM; Yeung CK
    Scand J Urol Nephrol; 2005; 39(1):78-81. PubMed ID: 15764277
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of topical tretinoin on non-sun-exposed human skin connective tissue: induction of tenascin but no major effect on collagen metabolism.
    Haapasaari KM; Kallioinen M; Tasanen K; Sutinen M; Annala AP; Risteli J; Oikarinen A
    Br J Dermatol; 1997 Jun; 136(6):891-900. PubMed ID: 9217822
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 1% pimecrolimus, 0.005% calcipotriol, and 0.1% betamethasone in the treatment of intertriginous psoriasis: a double-blind, randomized controlled study.
    Kreuter A; Sommer A; Hyun J; Bräutigam M; Brockmeyer NH; Altmeyer P; Gambichler T
    Arch Dermatol; 2006 Sep; 142(9):1138-43. PubMed ID: 16983001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A new scalp formulation of calcipotriene plus betamethasone compared with its active ingredients and the vehicle in the treatment of scalp psoriasis: a randomized, double-blind, controlled trial.
    Jemec GB; Ganslandt C; Ortonne JP; Poulin Y; Burden AD; de Unamuno P; Berne B; Figueiredo A; Austad J
    J Am Acad Dermatol; 2008 Sep; 59(3):455-63. PubMed ID: 18694678
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy of a betamethasone dipropionate topical glycol preparation in the management of severe psoriasis.
    Leer JA
    Clin Ther; 1980; 3(3):156-67. PubMed ID: 7006810
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adrenal suppression with high-potency corticosteroid ointment formulations in normal subjects.
    Novak E; Francom SF; Schlagel CA
    Clin Ther; 1983; 6(1):59-71. PubMed ID: 6370438
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.